Yes, nothing wrong with still being skeptical. Company still needs to show a decent growth in revenue and sales and/or use of prizma and patch. Its still just a promise. That said, its looking much better now than it did a year ago and as bad as the Covid pandemic has been in general, it has thrown the spotlight on the need and benefits of Telehealth / mHealth and these stocks are doing very nicely in the US at the moment. I'm cautiously optimistic.
GMV Price at posting:
3.9¢ Sentiment: Hold Disclosure: Held
